X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11374) 11374
Book Review (1497) 1497
Publication (548) 548
Conference Proceeding (20) 20
Book Chapter (11) 11
Book / eBook (7) 7
Dissertation (7) 7
Magazine Article (6) 6
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10797) 10797
humans (10040) 10040
antimetabolites, antineoplastic - administration & dosage (6328) 6328
female (6145) 6145
male (6016) 6016
oncology (4673) 4673
middle aged (4634) 4634
aged (4267) 4267
antimetabolites, antineoplastic - therapeutic use (4136) 4136
adult (3329) 3329
chemotherapy (3109) 3109
antimetabolites, antineoplastic - adverse effects (2925) 2925
deoxycytidine - analogs & derivatives (2869) 2869
fluorouracil - administration & dosage (2731) 2731
cancer (2553) 2553
antineoplastic combined chemotherapy protocols - therapeutic use (2439) 2439
treatment outcome (2418) 2418
animals (2258) 2258
5-fluorouracil (1752) 1752
deoxycytidine - administration & dosage (1748) 1748
pharmacology & pharmacy (1705) 1705
antimetabolites, antineoplastic - pharmacology (1517) 1517
drug administration schedule (1428) 1428
fluorouracil - therapeutic use (1377) 1377
aged, 80 and over (1358) 1358
fluorouracil (1287) 1287
deoxycytidine - therapeutic use (1252) 1252
gemcitabine (1245) 1245
therapy (1225) 1225
mice (1218) 1218
combined modality therapy (1145) 1145
antimetabolites, antineoplastic - pharmacokinetics (1099) 1099
methotrexate - administration & dosage (1039) 1039
fluorouracil - adverse effects (1002) 1002
capecitabine (1001) 1001
methotrexate (956) 956
care and treatment (954) 954
medicine & public health (947) 947
carcinoma (945) 945
deoxycytidine - adverse effects (923) 923
dose-response relationship, drug (923) 923
drug combinations (915) 915
survival analysis (889) 889
antineoplastic combined chemotherapy protocols - adverse effects (888) 888
adenocarcinoma - drug therapy (881) 881
antineoplastic agents - administration & dosage (870) 870
hematology (869) 869
survival rate (855) 855
colorectal neoplasms - drug therapy (852) 852
disease-free survival (850) 850
pancreatic neoplasms - drug therapy (836) 836
retrospective studies (836) 836
time factors (833) 833
neoplasm staging (801) 801
cisplatin - administration & dosage (789) 789
administration, oral (787) 787
prognosis (773) 773
fluorouracil - analogs & derivatives (767) 767
cell line, tumor (763) 763
chemotherapy, adjuvant (760) 760
infusions, intravenous (751) 751
surgery (733) 733
antineoplastic combined chemotherapy protocols - administration & dosage (731) 731
trial (726) 726
research (716) 716
adolescent (699) 699
tegafur - administration & dosage (699) 699
rats (697) 697
survival (683) 683
toxicity (679) 679
abridged index medicus (672) 672
cisplatin (650) 650
radiotherapy (645) 645
analysis (643) 643
follow-up studies (634) 634
breast neoplasms - drug therapy (630) 630
leucovorin - administration & dosage (618) 618
lung neoplasms - drug therapy (614) 614
colorectal cancer (595) 595
antineoplastic agents (588) 588
stomach neoplasms - drug therapy (588) 588
neoplasms - drug therapy (578) 578
pancreatic cancer (573) 573
remission induction (557) 557
drug therapy (554) 554
child (551) 551
pharmacokinetics (551) 551
tumors (547) 547
antineoplastic agents, phytogenic - administration & dosage (541) 541
liver neoplasms - secondary (537) 537
fluorouracil - pharmacology (536) 536
oxonic acid - administration & dosage (521) 521
antineoplastic agents - therapeutic use (520) 520
cytarabine - administration & dosage (519) 519
apoptosis (515) 515
antimitotic agents (510) 510
health aspects (508) 508
methotrexate - adverse effects (500) 500
liver neoplasms - drug therapy (496) 496
phase-ii (492) 492
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9861) 9861
Japanese (889) 889
French (168) 168
German (125) 125
Chinese (97) 97
Russian (74) 74
Italian (54) 54
Spanish (44) 44
Polish (15) 15
Hungarian (11) 11
Danish (9) 9
Lithuanian (9) 9
Norwegian (9) 9
Portuguese (5) 5
Ukrainian (5) 5
Bulgarian (4) 4
Hebrew (4) 4
Czech (3) 3
Dutch (3) 3
Korean (2) 2
Swedish (2) 2
Finnish (1) 1
Kurdish (1) 1
Romanian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 21, pp. 3239 - 3246
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 3, pp. 215 - 221
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2013, Volume 31, Issue 23, pp. 2895 - 2902
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1011 - 1024
Summary Background The ESPAC-3 trial showed that adjuvant gemcitabine is the standard of care based on similar survival to and less toxicity than adjuvant... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | THERAPY | ADENOCARCINOMA | CHEMORADIOTHERAPY | FOLINIC ACID | MODEL | CHEMOTHERAPY | Capecitabine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Carcinoma, Pancreatic Ductal - surgery | Antimetabolites, Antineoplastic - administration & dosage | Pancreatic Neoplasms - drug therapy | Aged, 80 and over | Adult | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - surgery | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Pancreatic Ductal - drug therapy | Capecitabine - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Antimitotic agents | Cancer patients | Care and treatment | Pancreatic cancer | Clinical trials | Product development | Metastasis | Comparative analysis | Antineoplastic agents | Studies | Antigens | Chemotherapy | Acids | Pragmatism | Pharmaceutical industry | Cancer therapies | Abdomen | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2012, Volume 23, Issue 11, pp. 2799 - 2805
Sorafenib is an oral anticancer agent targeting Ras-dependent signaling and angiogenic pathways. A phase I trial demonstrated that the combination of... 
Advanced pancreatic cancer | Gemcitabine | Sorafenib | Phase III randomized trial | MULTICENTER | MONOTHERAPY | sorafenib | SOLID TUMORS | BEVACIZUMAB | ADENOCARCINOMA | BRAF INHIBITORS | COMBINATION | RAF/MEK/ERK PATHWAY | CHEMOTHERAPY | phase III randomized trial | ONCOLOGY | gemcitabine | ONCOLOGY GROUP | advanced pancreatic cancer | Niacinamide - analogs & derivatives | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Antimetabolites, Antineoplastic - administration & dosage | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Aged, 80 and over | Placebos | Adult | Deoxycytidine - adverse effects | Female | Double-Blind Method | Deoxycytidine - administration & dosage | Niacinamide - adverse effects | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Niacinamide - administration & dosage | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Antimetabolites, Antineoplastic - therapeutic use | Phenylurea Compounds - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Ribonucleotide Reductases - antagonists & inhibitors | Antimetabolites, Antineoplastic - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 4/2008, Volume 100, Issue 8, pp. 542 - 551
Background Among breast cancer patients, nonresponse to initial neoadjuvant chemotherapy is associated with unfavorable outcome. We compared the response of... 
THERAPY | GEPARDUO | ONCOLOGY | PROGNOSIS | CARCINOMA | CHEMOTHERAPY | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Vinblastine - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Breast Neoplasms - chemistry | Carcinoma, Ductal, Breast - drug therapy | Fluorouracil - administration & dosage | Vinblastine - analogs & derivatives | Mastectomy, Segmental | Adult | Female | Breast Neoplasms - diagnostic imaging | Chemotherapy, Adjuvant | Doxorubicin - administration & dosage | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Biomarkers, Tumor - analysis | Deoxycytidine - administration & dosage | Ultrasonography, Mammary | Treatment Outcome | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Aged | Carcinoma, Lobular - drug therapy | Patient Compliance | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Germany | Chemotherapy | Breast cancer | Drug therapy | Comparative analysis | Health aspects | Cancer | Side effects | Toxicity | Clinical outcomes | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 21, pp. 2670 - 2677
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2013, Volume 31, Issue 23, pp. 2849 - 2853
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 03/2011, Volume 89, Issue 3, pp. 387 - 391
Journal Article
BLOOD, ISSN 0006-4971, 06/2017, Volume 129, Issue 25, pp. 3304 - 3313
Patients with myeloid leukemia of Down syndrome (ML-DS) have favorable event-free survival (EFS), but experience significant treatment-related morbidity and... 
MULTICENTER TRIAL | POPULATION | INFECTIOUS COMPLICATIONS | ACUTE MEGAKARYOBLASTIC LEUKEMIA | HIGH CURE RATE | MUTATIONS | HEMATOLOGY | GATA1 | EXPRESSION | MEGAKARYOCYTIC LEUKEMIA | CHEMOTHERAPY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Cytarabine - therapeutic use | Humans | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Cytarabine - adverse effects | Leukemia, Myeloid, Acute - complications | Antimetabolites, Antineoplastic - administration & dosage | Neoplasm, Residual - diagnosis | Down Syndrome - complications | Leukemia, Myeloid, Acute - drug therapy | Female | Cytogenetic Analysis | Daunorubicin - administration & dosage | Myelodysplastic Syndromes - drug therapy | Daunorubicin - therapeutic use | Treatment Outcome | Myelodysplastic Syndromes - complications | Cytarabine - administration & dosage | Neoplasm, Residual - genetics | Daunorubicin - adverse effects | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Down Syndrome - genetics | Myelodysplastic Syndromes - genetics | Leukemia, Myeloid, Acute - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2006, Volume 24, Issue 24, pp. 3946 - 3952
Journal Article